Cardiac resynchronization therapy in congestive heart failure: The state of the art and future perspectives

Area of Science:

• Cardiology
• Medical Technology

Background:

• Congestive heart failure (CHF) significantly contributes to global morbidity and mortality.
• Intraventricular conduction disturbances, like left bundle branch block, affect up to 50% of CHF patients, causing ventricular dyssynchrony and impaired cardiac function.

Purpose of the Study:

• To review the pathophysiology of ventricular dyssynchrony in CHF.
• To evaluate the clinical trial results of cardiac resynchronization therapy (CRT) for CHF patients.

Main Methods:

• Review of recent clinical trials on CRT in CHF patients with conduction delays.
• Analysis of CRT's impact on cardiac function, exercise tolerance, and quality of life.

Main Results:

• CRT improves cardiac function class, exercise tolerance, and quality of life within 12 months.
• CRT reduces hospitalizations and the need for intravenous medications for heart failure exacerbations.
• CRT has not demonstrated a reduction in overall cardiac mortality in the short to medium term.

Conclusions:

• Cardiac resynchronization therapy offers significant short-to-medium term clinical benefits for CHF patients with specific conduction abnormalities.
• Ventricular dyssynchrony is a key pathophysiological factor addressed by CRT.
• Further research may be needed to ascertain long-term mortality benefits of CRT.